Renal fibrosis is considered to be the final common outcome of chronic kidney disease. Dipeptidyl peptidase-4 (DPP-4) inhibitors have demonstrated protective effects against diabetic kidney disease. However, the anti-fibrotic effect of evogliptin, a DPP-4 inhibitor, has not been studied. Here, we report the beneficial effects of evogliptin on unilateral ureteral obstruction (UUO)-induced renal fibrosis in mice. Evogliptin attenuated UUO-induced renal atrophy and tubulointerstitial fibrosis. Immunohistochemistry and Western blotting demonstrated that evogliptin treatment inhibits pro-fibrotic gene expressions and extracellular matrix production. In vitro findings showed that the beneficial effects of evogliptin on renal fibrosis are mediated by inhibition of the transforming growth factor-β/Smad3 signaling pathway. The present study demonstrates that evogliptin is protective against UUO-induced renal fibrosis, suggesting that its clinical applications could extend to the treatment of kidney disease of non-diabetic origin.

Citations

Citations to this article as recorded by  

• Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis
  Birte Ohm, Isabelle Moneke, Wolfgang Jungraithmayr
  British Journal of Pharmacology.2023; 180(22): 2846.     CrossRef
• Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition
  Biwei Pei, Na Zhang, Tingting Pang, Gengyun Sun
  Molecular and Cellular Biochemistry.2022; 477(4): 995.     CrossRef
• Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes
  Yewon Na, Soo Wan Kim, Ie Byung Park, Soo Jung Choi, Seungyoon Nam, Jaehun Jung, Dae Ho Lee
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(11): 3022.     CrossRef
• Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells
  Hye-Young Seo, So-Hee Lee, Eugene Han, Jae Seok Hwang, Sol Han, Mi Kyung Kim, Byoung Kuk Jang
  International Journal of Molecular Sciences.2022; 23(19): 11636.     CrossRef
• Optimization and validation of a fluorogenic dipeptidyl peptidase 4 enzymatic assay in human plasma
  Hyunyee Yoon, Su Hee Cho, Yu Rim Seo, Kyung-Sang Yu, Sung Sup Park, Moon Jung Song
  Analytical Biochemistry.2021; 612: 113952.     CrossRef
• Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside
  Sungjin Chung, Gheun-Ho Kim
  Life.2021; 11(5): 389.     CrossRef
• Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
  Xin Huang, Yimin Khoong, Chengyao Han, Dai Su, Hao Ma, Shuchen Gu, Qingfeng Li, Tao Zan
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)
  Gyuri Kim, Soo Lim, Hyuk‐Sang Kwon, Ie B. Park, Kyu J. Ahn, Cheol‐Young Park, Su K. Kwon, Hye S. Kim, Seok W. Park, Sin G. Kim, Min K. Moon, Eun S. Kim, Choon H. Chung, Kang S. Park, Mikyung Kim, Dong J. Chung, Chang B. Lee, Tae H. Kim, Moon‐Kyu Lee
  Diabetes, Obesity and Metabolism.2020; 22(9): 1527.     CrossRef

• Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus

  
  Eugene Han, Minyoung Lee, Yong-ho Lee, Hye Soon Kim, Byung-wan Lee, Bong-Soo Cha, Eun Seok Kang
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4113.     CrossRef
• Efficacy and safety of novel dipeptidyl-peptidase-4 inhibitor evogliptin in the management of type 2 diabetes mellitus: A meta-analysis
  Deep Dutta, Saptarshi Bhattacharya, Aishwarya Krishnamurthy, LokeshKumar Sharma, Meha Sharma
  Indian Journal of Endocrinology and Metabolism.2020; 24(5): 434.     CrossRef

Citations

Citations to this article as recorded by  

• Novel pharmacological interventions for diabetic kidney disease
  Seng Kiong Tan, Jairo A. Pinzon-Cortes, Mark E. Cooper
  Current Opinion in Nephrology & Hypertension.2024; 33(1): 13.     CrossRef
• Integrated analysis reveals crosstalk between pyroptosis and immune regulation in renal fibrosis
  Fengxia Bai, Longchao Han, Jifeng Yang, Yuxiu Liu, Xiangmeng Li, Yaqin Wang, Ruijian Jiang, Zhaomu Zeng, Yan Gao, Haisong Zhang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Di (2-ethylhexyl) phthalate and polystyrene microplastics co-exposure caused oxidative stress to activate NF-κB/NLRP3 pathway aggravated pyroptosis and inflammation in mouse kidney
  Shanshan Li, Xuedie Gu, Muyue Zhang, Qihang Jiang, Tong Xu
  Science of The Total Environment.2024; 926: 171817.     CrossRef
• Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation
  Linfeng Zheng, Wenjuan Mei, Jing Zhou, Xin Wei, Zhijuan Huang, Xiaozhen Lin, Li Zhang, Wei Liu, Qian Wu, Jinhong Li, Yan Yan
  Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
• Gemigliptin mitigates TGF-β-induced renal fibrosis through FGF21-mediated inhibition of the TGF-β/Smad3 signaling pathway
  Jun-Kyu Byun, Gwon-Soo Jung
  Biochemical and Biophysical Research Communications.2024; 733: 150425.     CrossRef
• Uncovering the Role of Anoikis-Related Genes in Modulating Immune Infiltration and Pathogenesis of Diabetic Kidney Disease
  Jiaqiong Lin, Yan Lin, Xiaoyong Li, Fei He, Qinyuan Gao, Yuanjun Wang, Zena Huang, Fu Xiong
  Journal of Inflammation Research.2024; Volume 17: 4975.     CrossRef
• Activation of NLRP3 inflammasome in patients with renal transplantation: relation to allograft dysfunction, inflammation, and renal fibrosis
  Hayam Abdel Meguid El Aggan, Hala Saddik El-Wakil, Sabah Abdel-Hady Mahmoud, Aya Ahmad Saad
  Alexandria Journal of Medicine.2024; 60(1): 249.     CrossRef
• Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease
  Yong Ji, Hu Hua, Zhanjun Jia, Aihua Zhang, Guixia Ding
  Kidney Diseases.2024; : 369.     CrossRef
• HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome
  Jialin Li, Qisheng Lin, Xinghua Shao, Shu Li, Xuying Zhu, Jingkui Wu, Shan Mou, Leyi Gu, Qin Wang, Minfang Zhang, Kaiqi Zhang, Jiayue Lu, Zhaohui Ni
  Cell Death & Disease.2023;[Epub]     CrossRef
• Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance
  Ya Liu, Haibo Lei, Wenyou Zhang, Qichang Xing, Renzhu Liu, Shiwei Wu, Zheng Liu, Qingzi Yan, Wencan Li, Xiang Liu, Yixiang Hu
  Cell Death & Disease.2023;[Epub]     CrossRef
• Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
  Yu Wang, Mingyue Jin, Chak Kwong Cheng, Qiang Li
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Hederagenin inhibits high glucose‐induced fibrosis in human renal cells by suppression of NLRP3 inflammasome activation through reducing cathepsin B expression
  Guohua Yang, Wang Yang, Hairong Jiang, Qing Yi, Wei Ma
  Chemical Biology & Drug Design.2023; 102(6): 1409.     CrossRef
• Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
  Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, Tae-Hwan Kwon
  Physiological Reviews.2023; 103(4): 2847.     CrossRef
• Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive
  Mahmoud S. Sabra, Fahmy K. Hemida, Essmat A. H. Allam
  BMC Nephrology.2023;[Epub]     CrossRef
• Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
  Yun Zhang, Song Zhang, Bolin Li, Yingchun Luo, Yongtai Gong, Xuexin Jin, Jiawei Zhang, Yun Zhou, Xiaozhen Zhuo, Zixi Wang, Xinbo Zhao, Xuejie Han, Yunlong Gao, Hui Yu, Desen Liang, Shiqi Zhao, Danghui Sun, Dingyu Wang, Wei Xu, Guangjin Qu, Wanlan Bo, Dan
  Cardiovascular Research.2022; 118(3): 785.     CrossRef
• The NLRP3 inflammasome in fibrosis and aging: The known unknowns
  Yanqing Liu, Xuezeng Xu, Wangrui Lei, Yuxuan Hou, Yan Zhang, Ran Tang, Zhi Yang, Ye Tian, Yanli Zhu, Changyu Wang, Chao Deng, Shaofei Zhang, Yang Yang
  Ageing Research Reviews.2022; 79: 101638.     CrossRef
• Research progress of endothelial‐mesenchymal transition in diabetic kidney disease
  Ying Chen, Hang Zou, Hongwei Lu, Hong Xiang, Shuhua Chen
  Journal of Cellular and Molecular Medicine.2022; 26(12): 3313.     CrossRef
• Exploring the mechanism of Shendi Bushen capsule in anti-renal fibrosis using metabolomics theory and network analysis
  Tianwei Meng, Hong Chang, Hongyu Meng
  Molecular Omics.2022; 18(9): 873.     CrossRef
• Gemigliptin suppresses salivary dysfunction in streptozotocin-induced diabetic rats
  Wan Seok Kang, Woo Kwon Jung, Su-Bin Park, Hyung Rae Kim, Junghyun Kim
  Biomedicine & Pharmacotherapy.2021; 137: 111297.     CrossRef
• Long‐Term Dipeptidyl Peptidase 4 Inhibition Worsens Hypertension and Renal and Cardiac Abnormalities in Obese Spontaneously Hypertensive Heart Failure Rats
  Edwin K. Jackson, Zaichuan Mi, Delbert G. Gillespie, Dongmei Cheng, Stevan P. Tofovic
  Journal of the American Heart Association.2021;[Epub]     CrossRef
• Disulfiram inhibits inflammation and fibrosis in a rat unilateral ureteral obstruction model by inhibiting gasdermin D cleavage and pyroptosis
  Yu Zhang, Ruicheng Zhang, Xiaohu Han
  Inflammation Research.2021; 70(5): 543.     CrossRef
• Inflammasome as an Effective Platform for Fibrosis Therapy
  Ting-Ting Chen, Feng Xiao, Nan Li, Shan Shan, Meng Qi, Zi-Ying Wang, Sheng-Nan Zhang, Wei Wei, Wu-Yi Sun
  Journal of Inflammation Research.2021; Volume 14: 1575.     CrossRef
• Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
  Xin Huang, Yimin Khoong, Chengyao Han, Dai Su, Hao Ma, Shuchen Gu, Qingfeng Li, Tao Zan
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Linagliptin Protects against Endotoxin-Induced Acute Kidney Injury in Rats by Decreasing Inflammatory Cytokines and Reactive Oxygen Species
  Tsung-Jui Wu, Yi-Jen Hsieh, Chia-Wen Lu, Chung-Jen Lee, Bang-Gee Hsu
  International Journal of Molecular Sciences.2021; 22(20): 11190.     CrossRef
• Psidium guajava Flavonoids Prevent NLRP3 Inflammasome Activation and Alleviate the Pancreatic Fibrosis in a Chronic Pancreatitis Mouse Model
  Guixian Zhang, Liming Tang, Hongbin Liu, Dawei Liu, Manxue Wang, Jun Cai, Weijun Liu, Wei Nie, Yi Zhang, Xiaomeng Yu
  The American Journal of Chinese Medicine.2021; 49(08): 2001.     CrossRef
• Effect and Regulation of the NLRP3 Inflammasome During Renal Fibrosis
  Hong Zhang, Zhengchao Wang
  Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
• Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway
  Honglian Li, Ruirui Lu, Yu Pang, Jicheng Li, Yiwen Cao, Hongxin Fu, Guoxing Fang, Qiuhe Chen, Bihao Liu, Junbiao Wu, Yuan Zhou, Jiuyao Zhou
  Frontiers in Pharmacology.2020;[Epub]     CrossRef
• Protective effect of exogenous hydrogen sulfide on diaphragm muscle fibrosis in streptozotocin-induced diabetic rats
  Rui Yang, Qiang Jia, Yan Li, Shomaila Mehmood
  Experimental Biology and Medicine.2020; 245(14): 1280.     CrossRef